Complete response in HER2+ leptomeningeal carcinomatosis from breast cancer with intrathecal trastuzumab.

Research output: Contribution to journalArticle

49 Citations (Scopus)

Fingerprint Dive into the research topics of 'Complete response in HER2+ leptomeningeal carcinomatosis from breast cancer with intrathecal trastuzumab.'. Together they form a unique fingerprint.

Medicine & Life Sciences